Myth 1: "Varicose Veins Are Only a Cosmetic Problem"
Fact: Varicose veins are a chronic medical condition that can progress to significant complications including chronic leg pain, persistent swelling, skin ulceration, and rarely, superficial thrombophlebitis or DVT. Untreated advanced venous disease (CEAP C4–C6) has measurable quality-of-life impacts equivalent to chronic cardiac or pulmonary conditions.
Myth 2: "Surgery Is the Only Definitive Treatment"
Fact: Surgical vein stripping has been largely replaced by minimally invasive endovenous techniques — including VenaBlock® — which achieve equivalent or superior long-term outcomes with significantly fewer complications, no general anesthesia, and same-day recovery.
Myth 3: "Vein Treatment Is Extremely Painful"
Fact: Modern non-thermal treatments like VenaBlock® require only one local anesthetic injection. Patient-reported pain scores during VenaBlock® procedures are consistently low, and post-procedure discomfort is manageable with over-the-counter analgesics.
Myth 4: "Treated Veins Always Come Back"
Fact: When the underlying reflux source is properly treated, long-term recurrence rates are low. VenaBlock® demonstrates 97.5% closure at 6 months and 93.75% at 12 months and 93.75% at 12 months (long-term follow-up data pending). New varicosities may develop over time as venous disease progresses, but this represents disease progression, not treatment failure.
Myth 5: "You Need General Anesthesia for Vein Treatment"
Fact: VenaBlock® is performed under local anesthesia in an outpatient office setting. No sedation, operating room, or hospital stay is required.
Myth 6: "You'll Be Off Your Feet for Weeks"
Fact: VenaBlock® patients walk out of the clinic and return to normal activities within 2 hours. Most return to work the same day or the following day.
Myth 7: "Compression Stockings Can Replace Treatment"
Fact: Compression stockings manage symptoms but do not treat the underlying reflux. Without closing the incompetent saphenous vein, disease will continue to progress despite compression use.
Myth 8: "Laser Treatment Is the Gold Standard"
Fact: Modern cyanoacrylate closure systems like VenaBlock® demonstrate equivalent long-term efficacy to laser ablation with fewer procedure-related side effects, no requirement for tumescent anesthesia, and superior patient comfort.
Myth 9: "Only Women Get Varicose Veins"
Fact: While varicose veins are more prevalent in women, approximately 15% of men develop significant varicose disease. Men tend to present at a more advanced CEAP classification due to delayed help-seeking behavior.
Myth 10: "It's Too Expensive"
Fact: Office-based endovenous closure with VenaBlock® is significantly less expensive than surgical treatment when total episode costs are considered. Many insurance systems now reimburse endovenous closure for symptomatic disease, and the procedure's efficiency translates to competitive per-case costs.